North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Source (In-house, Outsourcing), By Product, By End Use (Independent Pharmacies, Long Term Care Facility), By Country, And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Region Wise Market Calculation
                       1.6.1 Region Wise Market: Base Estimates
                       1.6.2 Global Market: CAGR Calculation
                   1.7 List of Secondary Sources
                   1.8 Objectives
                       1.8.1 Objective - 1: Understanding market dynamics
                       1.8.2 Objective - 2: Understanding market estimates and forecasts
                       1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
                       1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 North America Unit Dose Manufacturing Market: Variables, Trends, & Scope
                   3.1 Market Segmentation and Scope
                   3.2 Market Dynamics
                       3.2.1 Market Driver Analysis
                           3.2.1.1 Increased Adoption of Unit Doses
                           3.2.1.2 Benefits of manufacturing unit doses over repackaging
                           3.2.1.3 Flourishing pharmaceutical industry
                       3.2.2 Market Restraint Analysis
                           3.2.2.1 Challenges associated with the adoption of manufactured unit doses
                   3.3 Penetration & Growth Prospect Mapping
                   3.4 COVID-19 Impact on the Market
                   3.5 Major Deals and Strategic Alliances Analysis
                   3.6 North America Unit Dose Manufacturing: Market Analysis Tools
                       3.6.1 Industry Analysis - Porter’s
                       3.6.3 PESTEL Analysis
Chapter 4 North America Unit Dose Manufacturing Market: Sourcing Segment Analysis
                   4.1 North America Unit Dose Manufacturing Market: Sourcing Market Share Analysis, 2020 & 2028
                   4.2 In-House
                       4.2.1 In House Market, 2016 - 2028 (USD Million)
                   4.3 Outsource
                       4.3.1 Outsource Market, 2016 - 2028 (USD Million)
Chapter 5 North America Unit Dose Manufacturing Market: Product Segment Analysis
                   5.1 North America Unit Dose Manufacturing Market: Product Market Share Analysis, 2020 & 2028
                   5.2 Liquid unit dose
                       5.2.1 Liquid Unit Dose Manufacturing market, 2016 - 2028 (USD Million)
                   5.3 Solid unit dose
                       5.3.1 Solid unit dose Manufacturing market, 2016 - 2028 (USD Million)
                   5.4 Others
                       5.4.1 Others market, 2016 - 2028 (USD Million)
Chapter 6 North America Unit Dose Manufacturing Market: End-use Segment Analysis
                   6.1 North America Unit Dose Manufacturing Market: End-use Market Share Analysis, 2020 & 2028
                   6.2 Independent Pharmacies
                       6.2.1 Independent Pharmacies Market, 2016 - 2028 (USD Million)
                   6.2 Long Term Care Facility
                       6.2.2. Long Term Care Facility Market, 2016 - 2028 (USD Million)
                   6.3 Hospitals
                       6.3.2. Hospitals Market, 2016 - 2028 (USD Million)
                   6.4 Others
                       6.4.2. Others Market, 2016 - 2028 (USD Million)
Chapter 7 North America Unit Dose Manufacturing Market: Country Analysis
                   7.1 North America Unit Dose Manufacturing Market: Country Market Share Analysis, 2020 & 2028
                   7.2 North America
                       7.2.1 North America North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
                       7.2.2 U.S.
                           7.2.2.1 U.S. North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
                       7.2.3 Canada
                           7.2.3.1 Canada North America Unit Dose Manufacturing Market, 2016 - 2028 (USD Million)
Chapter 8 Company Profiles
                   8.1 Catalent Inc
                       8.1.1 Company Overview
                       8.1.2 Service Benchmarking
                       8.1.3 Financial Performance
                       8.1.4 Strategic Intiatives
                   8.2 Unither Pharmaceuticals
                       8.2.1 Company Overview
                       8.2.2 Financial Performance
                       8.2.3 Service Benchmarking
                       8.2.5 Strategic Initiatives
                   8.3 ThermoFisher Pantheon
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.2 Service Benchmarking
                       8.3.3 Strategic Initiatives
                   8.4 Corden Pharma.
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 Service Benchmarking
                   8.5 Mikart
                       8.5.1 Company Overview
                       8.5.2 Financial Performance
                       8.5.3 Service Benchmarking
                   8.6 Tape Mark
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.3 Service Benchmarking
                   8.7 Renaissance Lakewood LLC
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 Service Benchmarking
                       8.7.4 Strategic Initiatives
                   8.8 Medical Packaging Inc
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 Service Benchmarking
                       8.8.4 Strategic Initiatives
                   8.9 American Health Packaging
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Service Benchmarking
                       8.9.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 4 North America Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 5 North America Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 6 U.S. Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 7 U.S. Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 8 U.S. Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)
Table 9 Canada Unit Dose Manufacturing Market, by Product, 2016 - 2028 (USD Million)
Table 10 Canada Unit Dose Manufacturing Market, by Source, 2016 - 2028 (USD Million)
Table 11 Canada Unit Dose Manufacturing Market, by End use, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America unit dose manufacturing market snapshot (2020)
Fig. 9 North America unit dose manufacturing market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 North America unit dose manufacturing market sourcing outlook: Segment dashboard
Fig. 16 North America unit dose manufacturing market: Sourcing movement analysis
Fig. 17 In-house market, 2016 - 2028 (USD Million)
Fig. 18 Outsourcing market, 2016 - 2028 (USD Million)
Fig. 19 North America unit dose manufacturing market product outlook: Segment dashboard
Fig. 20 North America unit dose manufacturing market: Product movement analysis
Fig. 21 Liquid unit dose market, 2016 - 2028 (USD Million)
Fig. 22 Solid unit dose market, 2016 - 2028 (USD Million)
Fig. 23 Others market, 2016 - 2028 (USD Million)
Fig. 24 North America unit dose manufacturing market end-use outlook: Segment dashboard
Fig. 25 North America unit dose manufacturing market: end-use movement analysis
Fig. 26 Independent Pharmacies market, 2016-2028 (USD Million)
Fig. 27 Long term facility market, 2016 - 2028 (USD Million)
Fig. 28 Hospitals market, 2016 - 2028 (USD Million)
Fig. 29 Others market, 2016 - 2028 (USD Million)
Fig. 30 Others market, 2016 - 2028 (USD Million)
Fig. 31 Regional market: Key takeaways
Fig. 32 Regional outlook, 2020 & 2028
Fig. 33 North America market, 2016 - 2028 (USD Million)
Fig. 34 U.S. market, 2016 - 2028 (USD Million)
Fig. 35 Canada market, 2016 - 2028 (USD Million)